Education
About Us
Working with TipRanks
Follow Us
Fisher & Paykel Healthcare Corporation Limited (AU:FPH)
:FPH
RESEARCH TOOLSreports
FPH Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$26.70 - AU$35.76
Previous CloseN/A
Volume151.81K
Average Volume (3M)431.67K
Market Cap
AU$20.19B
Enterprise ValueN/A
Total Cash (Recent Filing)AU$116.60M
Total Debt (Recent Filing)$150.90M
Price to Earnings (P/E)59.2
Beta0.35
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jun 24, 2025Dividend Yield1.45%
Share Statistics
EPS (TTM)0.35
Shares Outstanding586,256,650
10 Day Avg. Volume516,889
30 Day Avg. Volume431,673
Financial Highlights & Ratios
PEG Ratio2.69
Price to Book (P/B)9.06
Price to Sales (P/S)0.00
P/FCF Ratio42.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$38.35Price Target Upside10.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Fisher & Paykel Healthcare Corporation Limited News
PremiumCompany Announcements
Fisher & Paykel CFO Reduces Shareholding
PremiumCompany Announcements
Fisher & Paykel Healthcare Reports Strong Earnings Growth
PremiumCompany Announcements
Fisher & Paykel Healthcare Surpasses $2 Billion Revenue Milestone
PremiumCompany Announcements
Fisher & Paykel Healthcare Announces Dividend Distribution
PremiumCompany Announcements
Fisher & Paykel Healthcare Achieves Record Revenue in 2025Options Prices
Currently, No data available
---
Ownership Overview
0.22% Insiders
―
Mutual Funds
― Other Institutional Investors
99.77% Public Companies and
Individual Investors
FPH FAQ
What was Fisher & Paykel Healthcare Corporation Limited’s price range in the past 12 months?
Fisher & Paykel Healthcare Corporation Limited lowest share price was AU$26.70 and its highest was AU$35.76 in the past 12 months.
What is Fisher & Paykel Healthcare Corporation Limited’s market cap?
Fisher & Paykel Healthcare Corporation Limited’s market cap is AU$20.19B.
When is Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date?
Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date is Nov 26, 2025 which is in 173 days.
How were Fisher & Paykel Healthcare Corporation Limited’s earnings last quarter?
Fisher & Paykel Healthcare Corporation Limited released its earnings results on May 27, 2025. The company reported AU$0.345 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.345.
Is Fisher & Paykel Healthcare Corporation Limited overvalued?
According to Wall Street analysts Fisher & Paykel Healthcare Corporation Limited’s price is currently Undervalued.
Does Fisher & Paykel Healthcare Corporation Limited pay dividends?
Fisher & Paykel Healthcare Corporation Limited pays a Semiannually dividend of AU$0.455 which represents an annual dividend yield of 1.45%. See more information on Fisher & Paykel Healthcare Corporation Limited dividends here
What is Fisher & Paykel Healthcare Corporation Limited’s EPS estimate?
Fisher & Paykel Healthcare Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fisher & Paykel Healthcare Corporation Limited have?
Fisher & Paykel Healthcare Corporation Limited has 586,256,650 shares outstanding.
What happened to Fisher & Paykel Healthcare Corporation Limited’s price movement after its last earnings report?
Fisher & Paykel Healthcare Corporation Limited reported an EPS of AU$0.345 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.777%.
Which hedge fund is a major shareholder of Fisher & Paykel Healthcare Corporation Limited?
Currently, no hedge funds are holding shares in AU:FPH
Company Description
Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
FPH Company Deck
FPH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant revenue and profit increases, supported by growth in both hospital and homecare segments. However, the impact of global tariffs and slowed growth in OSA mask revenue were notable challenges. Overall, the positive achievements outweighed the challenges, indicating a strong performance outlook.Read More>FPH Stock 12 Month Forecast
Average Price Target
AU$38.35
▲(10.46%Upside)
Technical Analysis
Fisher & Paykel Healthcare Corporation Limited
―
Resmed
―
Inogen
―
Masimo
―
Insulet
―
Lemaitre Vascular
―
Globus Medical
―